Review Article
Current state of prognostication, therapy and prospective innovations for Barrett’s-related esophageal adenocarcinoma: a literature review
Journal of Gastrointestinal Oncology
2021;
12
(4)
:1197-1214
.
(30 August 2021)
Original Article
Magnetic resonance elastography can predict the development of hepatocellular carcinoma: a meta-analysis and systematic review
Journal of Gastrointestinal Oncology
2021;
12
(4)
:1215-1222
.
(30 August 2021)
Clinical value of lymph node dissection for stage T1b mid-thoracic esophageal squamous cell carcinoma
Journal of Gastrointestinal Oncology
2021;
12
(4)
:1223-1227
.
(30 August 2021)
Evaluating prognostic value and relevant gene signatures of tumor microenvironment characterization in esophageal carcinoma
Journal of Gastrointestinal Oncology
2021;
12
(4)
:1228-1240
.
(30 August 2021)
Construction and evaluation of prognostic models for esophageal cancer patients with distant and non-distant metastases: providing a reference process for clinical diagnosis and treatment
Journal of Gastrointestinal Oncology
2021;
12
(4)
:1241-1254
.
(30 August 2021)
Effectiveness of telerehabilitation on short-term quality of life of patients after esophageal cancer surgery during COVID-19: a single-center, randomized, controlled study
Journal of Gastrointestinal Oncology
2021;
12
(4)
:1255-1264
.
(30 August 2021)
The relationship between the number of circulating tumor cells and the prognosis in patients with esophageal squamous cell carcinoma
Journal of Gastrointestinal Oncology
2021;
12
(4)
:1265-1276
.
(30 August 2021)
Comparative study on short-term efficacy of single incision plus one (SI+1) port and multiportal 3D laparoscopic minimally invasive esophagectomy
Journal of Gastrointestinal Oncology
2021;
12
(4)
:1277-1284
.
(30 August 2021)
Prognostic performance of different lymph node classification systems in young gastric cancer
Journal of Gastrointestinal Oncology
2021;
12
(4)
:1285-1300
.
(30 August 2021)
Clinicopathologic differences and mortality among Latinos and non-Latino whites with gastric cancer at a majority-minority cancer center in South Texas
Journal of Gastrointestinal Oncology
2021;
12
(4)
:1301-1307
.
(30 August 2021)
Disparities and survival in newly diagnosed gastric cancer in Hispanic patients in the United States: a propensity score matched analysis
Journal of Gastrointestinal Oncology
2021;
12
(4)
:1308-1325
.
(30 August 2021)
Slug and CD133 expression are associated with peritoneal carcinomatosis and survival in gastric cancer
Journal of Gastrointestinal Oncology
2021;
12
(4)
:1326-1337
.
(30 August 2021)
Decreased albumin-to-alkaline phosphatase ratio predicted poor survival of resectable gastric cancer patients
Journal of Gastrointestinal Oncology
2021;
12
(4)
:1338-1350
.
(30 August 2021)
Value of multiphase contrast-enhanced CT with three-dimensional reconstruction in detecting depth of infiltration, lymph node metastasis, and extramural vascular invasion of gastric cancer
Journal of Gastrointestinal Oncology
2021;
12
(4)
:1351-1362
.
(30 August 2021)
AKT inhibits the phosphorylation level of H2A at Tyr57 via CK2α to promote the progression of gastric cancer
Journal of Gastrointestinal Oncology
2021;
12
(4)
:1363-1373
.
(30 August 2021)
Diagnostic and prognostic value of MATN3 expression in gastric carcinoma: TCGA database mining
Journal of Gastrointestinal Oncology
2021;
12
(4)
:1374-1383
.
(30 August 2021)
Differential analysis of RNA methylation regulators in gastric cancer based on TCGA data set and construction of a prognostic model
Journal of Gastrointestinal Oncology
2021;
12
(4)
:1384-1397
.
(30 August 2021)
Predictive values profiling of interleukin-2, interleukin-8, tumor necrosis factor-α, procalcitonin, and C-reactive protein in critical gastrointestinal cancer patients
Journal of Gastrointestinal Oncology
2021;
12
(4)
:1398-1406
.
(30 August 2021)
Anatomical observation and clinical significance of the left gastric vein in laparoscopic radical gastrectomy
Journal of Gastrointestinal Oncology
2021;
12
(4)
:1407-1415
.
(30 August 2021)
Neoadjuvant intraperitoneal and systemic paclitaxel combined with apatinib and S-1 chemotherapy for conversion therapy in gastric cancer patients with positive exfoliative cytology: a prospective study
Journal of Gastrointestinal Oncology
2021;
12
(4)
:1416-1427
.
(30 August 2021)
Candidate oncogene circularNOP10 mediates gastric cancer progression by regulating miR-204/SIRT1 pathway
Journal of Gastrointestinal Oncology
2021;
12
(4)
:1428-1443
.
(30 August 2021)
Lymph node metastasis risk factors and applicability of endoscopic submucosal dissection in mixed-type early gastric cancer in Chinese patients
Journal of Gastrointestinal Oncology
2021;
12
(4)
:1444-1453
.
(30 August 2021)
Microwave ablation for colorectal cancer metastasis to the liver: a single-center retrospective analysis
Journal of Gastrointestinal Oncology
2021;
12
(4)
:1454-1469
.
(30 August 2021)
Prognostic value of the ratio of carcinoembryonic antigen concentration to maximum tumor diameter in patients with stage II colorectal cancer
Journal of Gastrointestinal Oncology
2021;
12
(4)
:1470-1481
.
(30 August 2021)
Factors associated with the refusal of surgery and the associated impact on survival in patients with rectal cancer using the National Cancer Database
Journal of Gastrointestinal Oncology
2021;
12
(4)
:1482-1497
.
(30 August 2021)
Development of a model to predict pathologic response to chemotherapy in patients with colorectal liver metastases
Journal of Gastrointestinal Oncology
2021;
12
(4)
:1498-1508
.
(30 August 2021)
Influence of first line chemotherapy strategy depending on primary tumor location in metastatic colorectal cancer
Journal of Gastrointestinal Oncology
2021;
12
(4)
:1509-1517
.
(30 August 2021)
Risk of delayed bleeding after hot snare polypectomy and endoscopic mucosal resection in the colorectum with continuation of anticoagulants
Journal of Gastrointestinal Oncology
2021;
12
(4)
:1518-1530
.
(30 August 2021)
The efficacy and safety of different radiotherapy doses in neoadjuvant chemoradiotherapy for locally advanced rectal cancer
Journal of Gastrointestinal Oncology
2021;
12
(4)
:1531-1542
.
(30 August 2021)
The predictive value of RNA binding proteins in colon adenocarcinoma
Journal of Gastrointestinal Oncology
2021;
12
(4)
:1543-1557
.
(30 August 2021)
Optimal adjuvant chemotherapy completion time for stage III colon cancer: a cohort study
Journal of Gastrointestinal Oncology
2021;
12
(4)
:1558-1567
.
(30 August 2021)
Outcomes of colorectal cancer surgery in nonagenarian patients: a multicenter retrospective study
Journal of Gastrointestinal Oncology
2021;
12
(4)
:1568-1576
.
(30 August 2021)
Expression, clinical significance and correlation of RUNX3 and HER2 in colorectal cancer
Journal of Gastrointestinal Oncology
2021;
12
(4)
:1577-1589
.
(30 August 2021)
A methylation-based prognostic model predicts survival in patients with colorectal cancer
Journal of Gastrointestinal Oncology
2021;
12
(4)
:1590-1600
.
(30 August 2021)
Effects of YAP1 and SFRP2 overexpression on the biological behavior of colorectal cancer cells and their molecular mechanisms
Journal of Gastrointestinal Oncology
2021;
12
(4)
:1601-1612
.
(30 August 2021)
Identification of hub genes and functional modules in colon adenocarcinoma based on public databases by bioinformatics analysis
Journal of Gastrointestinal Oncology
2021;
12
(4)
:1613-1624
.
(30 August 2021)
A dual-targeted molecular therapy of PP242 and cetuximab plays an anti-tumor effect through EGFR downstream signaling pathways in colorectal cancer
Journal of Gastrointestinal Oncology
2021;
12
(4)
:1625-1642
.
(30 August 2021)
Comparative analysis of clinical, treatment, and survival characteristics of signet ring cell and adenocarcinoma of esophagus
Journal of Gastrointestinal Oncology
2021;
12
(4)
:1643-1660
.
(30 August 2021)
Preoperative serum fibrinogen as a valuable predictor in the nomogram predicting overall survival of postoperative patients with gallbladder cancer
Journal of Gastrointestinal Oncology
2021;
12
(4)
:1661-1672
.
(30 August 2021)
Integrative analysis of TNFRSF6B as a potential therapeutic target for pancreatic cancer
Journal of Gastrointestinal Oncology
2021;
12
(4)
:1673-1690
.
(30 August 2021)
Hypoxia promotes pancreatic cancer cell migration, invasion, and epithelial-mesenchymal transition via modulating the FOXO3a/ DUSP6/ERK axis
Journal of Gastrointestinal Oncology
2021;
12
(4)
:1691-1703
.
(30 August 2021)
The expression and prognostic value of REXO4 in hepatocellular carcinoma
Journal of Gastrointestinal Oncology
2021;
12
(4)
:1704-1717
.
(30 August 2021)
Prognostic factors of unresectable hepatocellular carcinoma treated with yttrium-90 radioembolization: results from a large cohort over 13 years at a single center
Journal of Gastrointestinal Oncology
2021;
12
(4)
:1718-1731
.
(30 August 2021)
Synergistic effects of arsenic trioxide combined with Salmonella typhimurium in treating the advanced hepatocellular carcinoma in rat models
Journal of Gastrointestinal Oncology
2021;
12
(4)
:1732-1742
.
(30 August 2021)
Ablative radiation therapy for hepatocellular carcinoma is associated with reduced treatment- and tumor-related liver failure and improved survival
Journal of Gastrointestinal Oncology
2021;
12
(4)
:1743-1752
.
(30 August 2021)
Proton stereotactic body radiation therapy for liver metastases—results of 5-year experience for 81 hepatic lesions
Journal of Gastrointestinal Oncology
2021;
12
(4)
:1753-1760
.
(30 August 2021)
Morphine promotes angiogenesis by activating PI3K/Akt/HIF-1α pathway and upregulating VEGF in hepatocellular carcinoma
Journal of Gastrointestinal Oncology
2021;
12
(4)
:1761-1772
.
(30 August 2021)
Bioinformatical identification of key genes regulated by IGF2BP2- mediated RNA N6-methyladenosine and prediction of prognosis in hepatocellular carcinoma
Journal of Gastrointestinal Oncology
2021;
12
(4)
:1773-1785
.
(30 August 2021)
The effect of the TP53 and RB1 mutations on the survival of hepatocellular carcinoma patients with different racial backgrounds
Journal of Gastrointestinal Oncology
2021;
12
(4)
:1786-1796
.
(30 August 2021)
XPA serves as an autophagy and apoptosis inducer by suppressing hepatocellular carcinoma in a PI3K/Akt/mTOR dependent manner
Journal of Gastrointestinal Oncology
2021;
12
(4)
:1797-1810
.
(30 August 2021)
miR-744-5p suppresses tumor proliferation and metastasis by targeting transforming growth factor-beta 1 (TGF-β1) in hepatocellular carcinoma (HCC)
Journal of Gastrointestinal Oncology
2021;
12
(4)
:1811-1822
.
(30 August 2021)
FAT10 promotes hepatocellular carcinoma (HCC) carcinogenesis by mediating P53 degradation and acts as a prognostic indicator of HCC
Journal of Gastrointestinal Oncology
2021;
12
(4)
:1823-1837
.
(30 August 2021)
Comparison of initial tumor responses to transarterial bland embolization and drug-eluting beads-transarterial chemoembolization in the management of hepatocellular carcinoma: a propensity-score matching analysis
Journal of Gastrointestinal Oncology
2021;
12
(4)
:1838-1850
.
(30 August 2021)
Urokinase plasminogen activator predicts poor prognosis in hepatocellular carcinoma
Journal of Gastrointestinal Oncology
2021;
12
(4)
:1851-1859
.
(30 August 2021)
N6-methyladenosine (m6A) regulatory gene divides hepatocellular carcinoma into three subtypes
Journal of Gastrointestinal Oncology
2021;
12
(4)
:1860-1872
.
(30 August 2021)
MD2 blockage prevents the migration and invasion of hepatocellular carcinoma cells via inhibition of the EGFR signaling pathway
Journal of Gastrointestinal Oncology
2021;
12
(4)
:1873-1883
.
(30 August 2021)
Risk characteristics with seven epithelial-mesenchymal transition-related genes are used to predict the prognosis of patients with hepatocellular carcinoma
Journal of Gastrointestinal Oncology
2021;
12
(4)
:1884-1894
.
(30 August 2021)
Underlying mechanism of sorafenib resistance in hepatocellular carcinoma: a bioinformatics study based on validated resistance-related genes
Journal of Gastrointestinal Oncology
2021;
12
(4)
:1895-1904
.
(30 August 2021)
Increased RBM12 expression predicts poor prognosis in hepatocellular carcinoma based on bioinformatics
Journal of Gastrointestinal Oncology
2021;
12
(4)
:1905-1926
.
(30 August 2021)
Screening potential prognostic biomarkers for portal vein emboli in patients with hepatocellular carcinoma
Journal of Gastrointestinal Oncology
2021;
12
(4)
:1927-1938
.
(30 August 2021)
Case Report
A HER2-mutant patient with late-stage duodenal adenocarcinoma benefited from anti-HER2 therapy and PD-1 inhibition: a case report
Journal of Gastrointestinal Oncology
2021;
12
(4)
:1939-1943
.
(30 August 2021)
